- $1.12bn
- $1.89bn
- $924.22m
- 68
- 72
- 12
- 50
Annual cashflow statement for Neogen, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 59.5 | 60.9 | 48.3 | -22.9 | -9.42 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 6.47 | 6.44 | 7.15 | 21.6 | 27.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.062 | -6.63 | -6.42 | -26.8 | -72.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 85.9 | 81.1 | 68 | 41 | 35.3 |
| Capital Expenditures | -24.1 | -26.7 | -24.4 | -65.8 | -111 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -64.7 | -78.9 | -72.8 | 267 | 82.1 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -88.8 | -106 | -97.2 | 201 | -29.3 |
| Financing Cash Flow Items | 0 | -1.09 | -1.12 | -19.3 | -0.538 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29.4 | 33.5 | 6.81 | -118 | 1.92 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.6 | 9.33 | -31.1 | 119 | 7.37 |